Back to Search
MICHAEL CALIGIURI, M.D.
M.D.
Hematology (Internal Medicine) Physician
NPI: 1669488565Individual
Specialties, Licenses & Credentials
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
35072689(OH)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
35.072689(OH)
Research & Publications (20)
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia.
PMID 17475912·Blood·2007
8-other
Recent advances in the treatment of transplant-related lymphoma.
PMID 16562366·Clin Adv Hematol Oncol·2006
6-review
A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia.
PMID 19660811·Leuk Res·2010
7-preclinical
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
PMID 19451432·J Clin Oncol·2009
8-other
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.
PMID 19553639·Blood·2009
7-preclinical
The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia.
PMID 19183192·Br J Haematol·2009
8-other
Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells.
PMID 19060242·Blood·2009
8-other
Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry.
PMID 19119168·J Am Dent Assoc·2009
8-other
Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22.
PMID 19244159·Blood·2009
8-other
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab.
PMID 19051009·Breast Cancer Res Treat·2009
3-trial
The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development.
PMID 18840707·Blood·2009
8-other
TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia.
PMID 19329776·Blood·2009
7-preclinical
A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.
PMID 19225537·Leukemia·2009
3-trial
TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells.
PMID 18768831·J Immunol·2008
7-preclinical
The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele.
PMID 18617636·Blood·2008
7-preclinical
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.
PMID 18809607·J Clin Oncol·2008
8-other
Tumor growth decreases NK and B cells as well as common lymphoid progenitor.
PMID 18784839·PLoS One·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 W 10TH AVE
COLUMBUS, OH 43210 - Phone
- (614) 293-8619
Quick Facts
- NPI
- 1669488565
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile